Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

SC-409: p38 inhibition with therapeutic potential for asthma, COPD and RA

June 1, 2006

Studies show improved airway function with arformoterol in COPD patients

June 1, 2006

ASM-002 exhibits antiinflammatory and bronchodilatory properties

May 30, 2006

ELB-526: selective PDE4 inhibitor demonstrating antineutrophilia and safety

May 30, 2006

Novel therapeutic agents for respiratory disorders disclosed in recent patent literature

May 29, 2006

Topigen begins phase II program for TPI-1020 in respiratory disorders

May 26, 2006

FDA clears ALK-Abello to begin phase I study of ragweed allergy vaccine tablet

May 25, 2006

Zenyth receives fourth milestone payment from Merck under asthma collaboration

May 23, 2006

Therapeutic agents for respiratory disorders described in recent patents

May 22, 2006

R-343 selected for advanced preclinical development as allergic asthma treatment

May 22, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...